ReviewTherapeutic advances in chronic disease2014
Update on the therapy of Behçet disease.
Review in Therapeutic advances in chronic disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
42 citing papers in PubMed, 117 citations in OpenAlex.
- Behçet's disease unraveled: Insights into clinical manifestations, diagnosis, and management.Medicine · 2025Review
- A Triple Therapeutic Regiment Consisted of Colchicine, Thalidomide and Total Glucosides of Paeony Is Effective and Well-Tolerated for Treating Mucocutaneous Involvement in Patients With Behcet's Disease.Immunity, inflammation and disease · 2024Article
- Rare Autoinflammatory Neutrophilic Dermatoses in Pregnancy: Literature Review.American journal of clinical dermatology · 2024Review
- Intestinal Behçet's and suspected intestinal Behçet's disease: a report of four surgical cases.Surgical case reports · 2024Article
- Behçet's disease with intestinal involvement: a case report and review of the literature.Journal of medical case reports · 2023Review
- Oral Lesions as the Primary Manifestations of Behçet's Disease: The Importance of Interdisciplinary Diagnostics-A Case Report.Biomedicines · 2023Article
- Behcet's disease in a patient with primary sclerosing cholangitis: a case report and literature review.Postepy dermatologii i alergologii · 2023Review
- Low density neutrophils are increased in patients with Behçet's disease but do not explain differences in neutrophil function.Journal of inflammation (London, England) · 2022Article
- Article
- New insights on multigenic autoinflammatory diseases.Therapeutic advances in musculoskeletal disease · 2022Review
- Colchicine for the treatment of COVID-19 patients: efficacy, safety, and model informed dosage regimens.Xenobiotica; the fate of foreign compounds in biological systems · 2021Article
- Integrative Medicine (Herbal Medicine Combined with Drug Therapy) for Behcet's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Pharmaceutics · 2021Review
- Behçet's disease presenting as bilateral occlusive retinal vasculitis in a young woman.BMJ case reports · 2021Article
- Article
- Chronic Budd-Chiari syndrome in Behçet's disease successfully managed with transjugular intrahepatic portosystemic shunt: a case report and literature review.Clinical journal of gastroenterology · 2020Review
- Evidence-based diagnosis and clinical practice guidelines for intestinal Behçet's disease 2020 edited by Intractable Diseases, the Health and Labour Sciences Research Grants.Journal of gastroenterology · 2020Article
- Genetic Polymorphisms in Transforming Growth Factor-β, Interferon-γ and Interleukin-6 Genes and Susceptibility to Behcet's Disease in Saudi Population.Pharmacogenomics and personalized medicine · 2020Article
- Lessons of the month 2: A case of Behçet's disease: 70% have ophthalmic involvement.Clinical medicine (London, England) · 2019Article
- Budd-Chiari syndrome in Behcet's disease: A report of two cases.Experimental and therapeutic medicine · 2019Article
- Budd-Chiari Syndrome in Behçet's Disease successfully managed with immunosuppressive and anticoagulant therapy: A case report and literature review.Intractable & rare diseases research · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Behçet disease is a chronic inflammatory systemic disorder, characterized by a relapsing and remitting course. It manifests with oral and genital ulcerations, skin lesions, uveitis, and vascular, central nervous system and gastrointestinal involvement. The main histopathological finding is a widespread vasculitis of the arteries and veins of any size. The cause of this disease is presumed to be multifactorial involving infectious triggers, genetic predisposition, and dysregulation of the immune system. As the clinical expression of Behçet disease is heterogeneous, pharmacological therapy is variable and depends largely on the severity of the disease and organ involvement. Treatment of Behçet disease continues to be based largely on anecdotal case reports, case series, and a few randomized clinical trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.